Medicared For All Logo

Shibu Varughese in Gretna, Louisiana

Home Louisiana Gretna

Shibu Varughese has Hematology/oncology as his primary medical specialty. Their primary office is: 433 Fairfield Ave in Gretna, Louisiana. There is an additional office location, for a total of two, for Shibu Varughese that can be viewed further down.

They're a part of the: Bethesda Medical Clinic, Llc medical group which has around 2 members. You can call their office at 504-265-8304 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2006 (around 18 years of experience). They are listed as doing telehealth appointments.


Shibu Varughese Office Phone and Directions

Shibu Varughese
Bethesda Medical Clinic, Llc
433 Fairfield Ave
Gretna, Louisiana 70056
504-265-8304


Patient Ratings
Please rate your experience with Shibu Varughese below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 504-265-8304


Enter a starting address:


Healthcare Info for Shibu Varughese

Additional Medical Specialties Include:
GERIATRIC MEDICINE, HOSPICE/PALLIATIVE CARE, INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2006
The Primary Medical Specialty for Shibu Varughese is listed as: Hematology/oncology
Approximate Years of Experience: 18
PAC (PECOS ID)#: 2062553985
NPI #: 1346475506
NPI Created On: 05/18/2009
NPI Last Updated Listed as: 04/14/2015
Primary Taxonomy Code: 183500000X
License Number:
PS31922
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Vantage Health Plan, Inc.
  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: MALAYALAM, ENGLISH, English, Malayalam.


Services and Procedures include:

  1. Aspiration and/or injection of large joint or joint capsule
  2. Hydration infusion into a vein
  3. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
  4. Infusion into a vein for therapy, prevention, or diagnosis
  5. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  6. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  7. New patient office or other outpatient visit, typically 45 minutes
  8. Established patient office or other outpatient visit, typically 5 minutes
  9. Established patient office or other outpatient, visit typically 25 minutes
  10. Established patient office or other outpatient, visit typically 40 minutes
  11. Initial hospital inpatient care, typically 70 minutes per day
  12. Subsequent hospital inpatient care, typically 35 minutes per day
  13. Hospital discharge day management, more than 30 minutes
  14. Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
  15. Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp
  16. Injection, ceftriaxone sodium, per 250 mg
  17. Injection, testosterone cypionate, 1 mg
  18. Injection, dexamethasone sodium phosphate, 1 mg
  19. Injection, ketorolac tromethamine, per 15 mg
  20. Injection, ondansetron hydrochloride, per 1 mg

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788139645

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788139647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788139649

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788139651

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781015843

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802071047

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802085069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802626941

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802793691

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14


Payments Total: $11

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783522637

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0894-31


Additional Office Locations

1. Ochsner Clinic Llc
1514 Jefferson Hwy
New Orleans, LA 70121
Group Members: 2,434

Phone: 504-265-8304

Enter a starting address:


Hematology/oncology Professionals in Gretna

120 Ochsner Blvd
Gretna, LA
Ochsner Clinic Llc

120 Ochsner Blvd
Gretna, LA
Ochsner Clinic Llc

Providers in Bethesda Medical Clinic, Llc

1.Amy Varughese

433 Fairfield Ave
Gretna La 70056-7033
Bethesda Medical Clinic, Llc
Endocrinology

2.Shibu Varughese

433 Fairfield Ave
Gretna La 70056-7033
Bethesda Medical Clinic, Llc
Hematology/oncology

View all 2 members of Bethesda Medical Clinic, Llc medical group